Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,012
datasets available to search
ShareScore release 0.9.0
Dataset results
2,012 results for “Kinase”
Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055
ClinicalTrials.gov study NCT00973076. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients With Advanced Solid Tumor
ClinicalTrials.gov study NCT04648254. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study
ClinicalTrials.gov study NCT01860456. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Tumor Kinase Inhibitor Concentrations Measured by PET
ClinicalTrials.gov study NCT02111889. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Pharmacokinetic Study of Genistein, a Tyrosine Kinase Inhibitor
ClinicalTrials.gov study NCT00001696. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis
ClinicalTrials.gov study NCT00570752. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor
ClinicalTrials.gov study NCT00543049. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel, With and Without Bevacizumab or Trastuzumab, and With Letrozole, in Participants With Locally Recurrent or Metastatic Breast Ca
ClinicalTrials.gov study NCT00960960. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Pre-existing Kinase Domain Mutations in Ph-positive Leukemias
ClinicalTrials.gov study NCT02643888. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
European Stop Tyrosine Kinase Inhibitor Study
ClinicalTrials.gov study NCT01596114. IPD Sharing: Not stated. Countries: 10. Publications: 7.
(PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic Mastocytosis
ClinicalTrials.gov study NCT03731260. IPD Sharing: Not stated. Countries: 13. Publications: 3.
Study of Oral Lucitanib (E-3810), a Dual VEGFR-FGFR Tyrosine Kinase Inhibitor, in Patients With Solid Tumors
ClinicalTrials.gov study NCT01283945. IPD Sharing: YES. Countries: 3. Publications: 2.
Lactate Compared to Creatine Kinase as Diagnostic Marker in Generalized Epileptic Seizure
ClinicalTrials.gov study NCT02926703. IPD Sharing: NO. Countries: 1. Publications: 1.
Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma
ClinicalTrials.gov study NCT01585974. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Inhibition of Rho Kinase (ROCK) With Fasudil as Disease-modifying Treatment for ALS
ClinicalTrials.gov study NCT03792490. IPD Sharing: UNDECIDED. Countries: 3. Publications: 3.
Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702
ClinicalTrials.gov study NCT00205478. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Interventional Study to Improve Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT01768689. IPD Sharing: NO. Countries: 1. Publications: 7.
Janus Kinase Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction
ClinicalTrials.gov study NCT03681275. IPD Sharing: NO. Countries: 1. Publications: 2.
Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCLC Patients With Acquired Resistance to EGFR-TKI
ClinicalTrials.gov study NCT04007835. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06326502. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.